JPWO2022265091A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022265091A5 JPWO2022265091A5 JP2023530421A JP2023530421A JPWO2022265091A5 JP WO2022265091 A5 JPWO2022265091 A5 JP WO2022265091A5 JP 2023530421 A JP2023530421 A JP 2023530421A JP 2023530421 A JP2023530421 A JP 2023530421A JP WO2022265091 A5 JPWO2022265091 A5 JP WO2022265091A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- conjugate
- acid sequence
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021101745 | 2021-06-18 | ||
| PCT/JP2022/024263 WO2022265091A1 (ja) | 2021-06-18 | 2022-06-17 | ヒトαシヌクレインのエピトープペプチド及び該ペプチドを含む医薬組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2022265091A1 JPWO2022265091A1 (https=) | 2022-12-22 |
| JPWO2022265091A5 true JPWO2022265091A5 (https=) | 2024-03-21 |
Family
ID=84527547
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023530421A Pending JPWO2022265091A1 (https=) | 2021-06-18 | 2022-06-17 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240270801A1 (https=) |
| EP (1) | EP4357354A1 (https=) |
| JP (1) | JPWO2022265091A1 (https=) |
| TW (1) | TW202306966A (https=) |
| WO (1) | WO2022265091A1 (https=) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200509968A (en) | 2002-11-01 | 2005-03-16 | Elan Pharm Inc | Prevention and treatment of synucleinopathic disease |
| AT506535B1 (de) * | 2008-02-22 | 2010-04-15 | Affiris Forschungs & Entwicklungs Gmbh | Vaccine enthaltend alpha-synuclein-mimotope auf basis von peptiden |
| AT508638B1 (de) * | 2009-08-21 | 2011-08-15 | Affiris Ag | Verwendung von peptiden und polypeptiden zur behandlung und/oder prävention von synukleinopathien |
| ES3044918T3 (en) | 2016-03-25 | 2025-11-27 | The Univ Of Osaka | Conjugate vaccine targeting disorder-causing in vivo protein |
| EP3638298A4 (en) * | 2017-06-16 | 2021-05-05 | United Neuroscience | PEPTIDE IMMUNOGENS FROM THE C-TERMINAL END OF ALPHA-SYNUCLEIN-PROTEIN AND FORMULATIONS THEREOF FOR THE TREATMENT OF SYNUCLEINOPATHIA |
| JP7689373B2 (ja) * | 2019-04-18 | 2025-06-06 | エイシー イミューン ソシエテ アノニム | 治療及び診断のための新規分子 |
-
2022
- 2022-06-17 JP JP2023530421A patent/JPWO2022265091A1/ja active Pending
- 2022-06-17 US US18/566,885 patent/US20240270801A1/en not_active Abandoned
- 2022-06-17 TW TW111122598A patent/TW202306966A/zh unknown
- 2022-06-17 WO PCT/JP2022/024263 patent/WO2022265091A1/ja not_active Ceased
- 2022-06-17 EP EP22825079.1A patent/EP4357354A1/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018171063A5 (https=) | ||
| JP2013543497A5 (https=) | ||
| JP2003529319A (ja) | ＨＩＶ−１ｇｐ４１を標的化する広範に中和する抗体を誘発する方法 | |
| JP2020503262A5 (ja) | アクチビンＩＩａ型受容体変異体および同変異体を含む医薬組成物 | |
| JP2012531219A5 (https=) | ||
| CA2862391A1 (en) | Stabilized antiviral fusion helices | |
| US20230330238A1 (en) | Chimeric conjugates for degradation of viral and host proteins and methods of use | |
| JP2026004299A5 (https=) | ||
| CN117327174A (zh) | 抗新型冠状病毒人源化多价结合蛋白及其应用 | |
| US20100092505A1 (en) | Method for Shielding Functional Sites or Epitopes on Proteins | |
| JPWO2022265091A5 (https=) | ||
| JP2006512049A (ja) | 免疫原コンジュゲート | |
| JPS59501866A (ja) | 腸内ウイルスに対するワクチン接種に有用なポリペプチド | |
| US20220380425A1 (en) | Angptl3 based vaccine for the treatment of liver disease | |
| EP1704167B1 (en) | A method to make a peptide-carrier conjugate with a high immunogenicity | |
| WO2017101786A1 (zh) | 一种多肽化合物及其制备方法与应用 | |
| MXPA03003849A (es) | Metodo de obtencion de estructuras antigenicas que potencian la reactividad cruzada especifica. | |
| CN121001737A (zh) | Tau和β淀粉样肽免疫原组合物及相关方法 | |
| JP7747273B2 (ja) | ＳＡＲＳ－ＣｏＶ－２由来のアミノ酸配列およびその利用 | |
| CN111511917A (zh) | 肽结合物 | |
| TW202306966A (zh) | 人類α突觸核蛋白之抗原決定位肽及包含該肽之醫藥組合物 | |
| JP2967956B2 (ja) | ペプチドまたはその塩 | |
| JP4568842B2 (ja) | 熱帯熱マラリア原虫のエノラーゼ蛋白質の部分ペプチドの製造方法 | |
| JP2026041716A (ja) | インターロイキン－６に対して指向される免疫応答を誘導するための免疫原性複合体 | |
| JP7854660B2 (ja) | コロナウイルスに対する多重抗原ペプチドおよびこれを含む免疫賦活化組成物 |